Moneycontrol PRO
HomeNewsBusinessCoronavirus impact: Banks seek clarity over new NPAs worth Rs 50,000 crore: Report

Coronavirus impact: Banks seek clarity over new NPAs worth Rs 50,000 crore: Report

On April 17, the RBI said the moratorium period will be excluded from NPA classification.

April 17, 2020 / 15:37 IST

State-run lenders have taken up with the Centre their worries over Rs 50,000 crore worth of loans turning into non-performing assets (NPAs) for March, the Business Standard has reported.

Loans overdue for over 90 days are classified as NPAs. On April 17, the Reserve Bank of India (RBI) said the moratorium period will be excluded from NPA classification.

Follow LIVE updates on the COVID-19 pandemic here

On March 27, the central bank had announced a three-month moratorium on term loans whose payments were due between March 1 and May 31. The moratorium is intended to provide borrowers relief during the nationwide lockdown.

"The borrowers, which were classified as special mention accounts-2 (SMA-2), turned into NPA worth over Rs 50,000 crore by the end of March for the entire banking system. These were accounts mainly belonging to the micro, small and medium enterprises (MSMEs)," a chief executive officer of a PSB told the Business Standard.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Moneycontrol could not independently verify the story.

Also read: Shaktikanta Das' silence on loan moratorium for NBFCs may spoil the liquidity party

The PSBs also sought clarity whether borrowings by NBFCs were part of the moratorium, the report said.

"The NBFCs somehow could manage in March but they are feeling the pressure in this month and May would become even more difficult," a banker told the paper.

Announcing more liquidity-easing measures on April 17, the RBI said, "NBFCs have flexibility under the prescribed accounting standards to consider such relief to their borrowers.” The central bank, however, did not specify if loans taken by NBFCs from banks are included in the moratorium.

Moneycontrol News
first published: Apr 17, 2020 03:37 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347